期刊文献+

急性冠状动脉综合征患者血清同型半胱氨酸脂联素及血清基质金属蛋白酶-9水平与冠状动脉病变关系的研究 被引量:5

Serum HCY,MMP-9 and APN are correlated with coronary artery pathological changes in the ACS patients
下载PDF
导出
摘要 目的检测急性冠状动脉综合征(ACS)患者外周血清同型半胱氨酸(HCY)、脂联素(APN)及血清基质金属蛋白酶-9(MMP-9)与冠状动脉病变支数及冠状动脉狭窄程度的相关性。方法选择住我院心内科经冠状动脉造影(CAG)诊断的患者共170例,其中ACS组95例、稳定型心绞痛(SA)组38例和非紫绀先天性心脏病(NCHD)组37例。以酶联免疫吸附测定(ELISA)分别测定患者外周血清HCY、APN及MMP-9水平;冠状动脉病变支数根据CAG评定。结果①ACS组患者外周血清HCY、MMP-9水平均高于NCHD组和SA组患者(P均<0.05);外周血清APN水平ACS组患者均明显低于NCHD组和SA组患者;NCHD组与SA组患者间3项指标比较差异均无统计学意义(P>0.05)。②ACS组患者外周血清HCY、MMP-9水平随冠状动脉病变支数增加而递增,而外周血清APN水平随冠状动脉病变支数增加而递减。结论①HCY、APN及MMP-9水平可能与冠状动脉易损斑块的病理生理相关。②HCY、APN及MMP-9水平的改变可能与冠状动脉粥样硬化发生发展相关。 Objective To detect homocysteine(HCY) and adiponectin(APN) and serum matrix metalloproteinases-9(MMP-9) in patients with acute coronary syndromes and to study their relationship to coronary lesions count and coronary artery stenosis degree.Methods One hundred and seventy patients diagnosed by CAG were enrolled in this study including the ACS group(n=95),SA group(n=38) and NCHD group(n=37).Peripheral blood HCY,APN and MMP-9 level were determined using ELISA;Coronary lesions count was assessed according to CAG.Results ①Peripheral HCY,MMP-9 levels in patients of the ACS groups are higher than those in the NCHD group and SA groups(P0.05).Peripheral APN level in patients of ACS groups were significantly lower than those in NCHD group and SA group,the differences of three indexes between NCHD group and SA groups are not statistically significant(P0.05).②Peripheral HCY and MMP-9 level in patients of the ACS groups increases with increasing of coronary lesions count,peripheral APN level in patients of ACS groups decreased with descending of coronary lesions count.Conclusion ①HCY,APN and MMP-9 level may be related to pathophysiology of coronary vulnerable plaques.②HCY,APN and MMP-9 level in the peripheral blood indicates the change of these 3 index may be related to occurrence and development of coronary artherosclerosis.
出处 《山西医药杂志(上半月)》 CAS 2011年第6期537-539,共3页 Shanxi Medical Journal
基金 湖南省医药卫生科研计划项目(C2010-015)
关键词 急性冠状动脉综合征 半胱氨酸 脂联素 基质金属蛋白酶类 Acute coronary syndromes Cysteine Adiponectin Matrix metalloproteinases
  • 相关文献

参考文献5

二级参考文献32

  • 1郑延松,郑秋甫,张丽萍,段留法.血清同型半胱氨酸水平与冠状动脉病变的关系[J].解放军医学杂志,2004,29(7):628-629. 被引量:4
  • 2刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 3李锦祥,柏萍,俞建华.冠心病患者同型半胱氨酸水平变化与血管内皮功能的关系[J].实用诊断与治疗杂志,2005,19(5):327-328. 被引量:13
  • 4-.国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组的报告.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(1):75-75.
  • 5World Health Organization. Definition,diagnosis and classification of dia betes mellitus and its complication. WHO/NCD/NCS, 1999, 31 - 32. ( http://whqlilxloc, who. int/hq/1999/WHO _ NCD _ NCS _ 99.2. pdf).
  • 6Mends S, Athanda SB, Naser M,et al. Association between J Int Med Res, 1999,27(1) :38 - 44.
  • 7Fanapour PC, Yug B, Kochar MS. Hyperhomocysteinemia: an additional cardiovascular risk factor. WMJ, 1999,98 : 51 - 54.
  • 8Verhoef P, Kok FJ, Kmyssen DACM,, et al. Homocysteine metabolism and risk of myocardial infarction: relation with Vitanmin B6, B 12 and folate [ J ]. Am J Epidemiol, 1996,143 ( 3 ) : 845.
  • 9Ubbink JB,Vermaak WJH,Van der merwe A,et al. Vitamin B6,B12 and folate nutritional status in men with hyperhomocysteinemia[ J ]. Am J Nutr, 1993,57(1) :47.
  • 10Gravo ML, Gloria LM,Sehub J, et al. Hyperhomocysteinemia in Chroni o.alcoholism:Correlation with folate. VitB12 and VitB6 Status[J]. Am J Clin Nutr,2003;63:220.

共引文献73

同被引文献40

  • 1苏汉文,李艳,李栋.血清同型半胱氨酸和性激素水平与老年男性冠心病相关性的研究[J].中华老年心脑血管病杂志,2007,9(2):134-134. 被引量:4
  • 2马梅,尹浩晔,贾文军,高雪梅,刘克强,齐新,孟东.踝臂指数与冠心病严重程度的相关性研究[J].山东医药,2007,47(16):60-61. 被引量:7
  • 3Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guide- lines for the management of patients with unstable angina/non - ST - ele- vation myocardial infarction: a report of the American college of cardiol- ogy/American heart association task force on practice guidelines [J]. J Am Coil Cardiol, 2007, 50 (1): el-e157.
  • 4Gensini GG. A more meaningful scoring system for determining the se- verity of coronary heart disease [J]. Am J Cardiol, 1983, 51 (3) : 606.
  • 5Sabatine MS, Morrow DA, Delemos JA, et al. Acute changes in cir- culating natriuretic peptide levels in relation to myocardial ischemia [J]. JAm Coil Cardiol, 2004, 44 (1): 1988-1995.
  • 6Estrada JLN, Rubinstein F, Bahit MC, et al. NT - probrain natri- uretic peptide predicts complexity and severity of the coronary lesions in patients with non - ST - elevation acute syndromes [ J ]. Am Heart J,2006, 15 (15): 1093-1097.
  • 7Eren NK, Ertas F, Yuksek U, et al. Additive prognostic value of NT -proBNP over TI MI risk score in intermediate -risk patients with acute coronary syndrome [ J ]. Turk Kardiyol Dern Ars, 2009, 37 (I): 1-8.
  • 8Blom HJ, Smulders Y, Overview of homocysteine and folate metabo- lism with special references to cardiovascular disease and neural tube defects [ J]. Journal of Inherited Metabolic Disease, 2011, 34 ( 1 ) : 75 - 81.
  • 9Heinz J, Kropf S, Luley C, et al. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis : a meta- analysis [J]. American Journal of Kidney Diseases, 2009, 54 (3) : 478 - 489.
  • 10金晔,陈玥,苏建荣.血清同型半胱氨酸的检测在心血管疾病中的临床应用[J].中国实验诊断学,2007,11(9):1190-1191. 被引量:10

引证文献5

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部